Target relapsed refractory
    multiple myeloma at the cell

    Get to the core

    with XPOVIO®
    (selinexor)

    The First and Only
    FDA-Approved
    Oral
    Medicine of its Kind

    XPOVIO may work when
    you’ve stopped responding to
    other treatments
    (lenalidomide,
    pomalidomide, bortezomib,
    carfilzomib, and daratumumab).